IGF2 and malignant mesothelioma: We recently found IGF-II to be a key driver of protein EphB4 ectopic expression in malignant mesothelioma cells and we identified a ubiquitin/UPS-associated post-transcriptional mechanism tightly regulating EphB4 protein degradation/stabilization [7].